5 FAQs About Immunotherapy for Renal Cell Carcinoma
Kidney cancer is one of the 10 most common cancers in both men and women–and the most common type of kidney cancer is called renal cell carcinoma. If caught and treated early, the prognosis is good. But until recently, doctors had few good options to offer patients whose cancer spread despite treatment.
All that is changing. In recent years, a new class of immunotherapy drugs, “checkpoint inhibitors,” was approved to treat certain types of skin and lung cancer. Since then, those drugs have shown promise fighting a lot of different cancers, including renal cell carcinoma.
Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced
or reprinted without permission from Healthgrades Operating Company, Inc. Use
of this information is governed by the Healthgrades User Agreement.